2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$6.08-$0.010 (-0.16%)
Price as of Jun 03, 2026 7:28 PM EDT- $387.9MMarket Cap
- 39.64%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$6.08-$0.010 (-0.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 216.1M +8.72% | 198.8M +3.18% | 192.6M -24.27% | 254.4M -5.32% | |
Cost of Revenue | 13.0M +15.29% | 11.3M -23.53% | 14.8M -39.07% | 24.3M -5.26% | |
Gross Profit | 203.1M +8.32% | 187.5M +5.41% | 177.8M -22.71% | 230.1M -5.33% | |
Sales and Marketing Expense | 238.0M +62.52% | 146.4M +29.70% | 112.9M -17.29% | 136.5M +10.03% | |
Research and Development Expense | -109.3M +46.81% | -74.4M -3.11% | -76.8M -10.43% | -85.8M +13.81% | |
Depreciation and Amortization Expense | 7.0M -3.66% | 7.3M +247.99% | 2.1M +37.86% | 1.5M +2.57% | |
Total Operating Expenses | 367.3M +53.39% | 239.4M +15.90% | 206.6M -16.71% | 248.1M +9.51% | |
Operating Profit | -151.2M +271.79% | -40.7M +191.43% | -14.0M -320.45% | 6.3M -84.99% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 12.5M -29.42% | 17.7M -12.58% | 20.3M +308.19% | 5.0M +2,397.99% | |
Income before Taxes | -138.6M +504.89% | -22.9M -461.59% | 6.3M -43.90% | 11.3M -73.33% | |
Income Taxes | 81.8M +2,134.99% | -4.0M -204.99% | 3.8M -23.78% | 5.0M -45.45% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -220.5M +1,066.53% | -18.9M -853.29% | 2.5M -60.02% | 6.3M -81.07% | |
Net Income from Continuing Operations Applicable to Common | -138.6M +504.89% | -22.9M -461.59% | 6.3M -43.90% | 11.3M -73.33% | |
Basic EPS and Net Income | -3.74 +1,033.33% | -0.33 -925.00% | 0.04 -63.64% | 0.11 -81.67% | |
Diluted EPS and Net Income | -3.74 +1,033.33% | -0.33 -925.00% | 0.04 -63.64% | 0.11 -81.03% | |
Basic Weighted Average Shares | 58.9M +1.34% | 58.1M +1.34% | 57.4M +1.63% | 56.5M +1.64% | |
Diluted Weighted Average Shares | 58.9M +1.34% | 58.1M +1.03% | 57.6M +1.01% | 57.0M +0.11% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 84.9M -17.07% | 102.3M -24.67% | 135.8M +0.59% | 135.0M +159.32% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 84.9M -17.07% | 102.3M -24.67% | 135.8M +0.59% | 135.0M -68.80% | |
Total Current Assets | 347.3M -20.88% | 438.9M +1.37% | 432.9M -16.63% | 519.3M +8.57% | |
Accumulated Depreciation | 12.6M +9.07% | 11.6M +3.45% | 11.2M +7.31% | 10.4M +11.11% | |
Property and Plant and Equipment and Net | 2.2M +5.44% | 2.1M +4.66% | 2.0M -20.83% | 2.6M -17.35% | |
Total Long-Term Assets | 2.2M +5.44% | 2.1M +4.66% | 2.0M -20.83% | 2.6M -17.35% | |
Total Assets | 488.9M -25.49% | 656.2M +1.20% | 648.4M +2.24% | 634.2M +6.81% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 145.2M +45.19% | 100.0M +14.01% | 87.7M -4.09% | 91.4M +22.87% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 9.5M -0.56% | 9.6M +8.61% | 8.8M +29.81% | 6.8M +54.90% | |
Total Liabilities | 161.8M +37.48% | 117.7M +13.65% | 103.5M -3.29% | 107.0M +20.46% | |
Retained Earnings | -394.8M +126.50% | -174.3M +12.16% | -155.4M -1.59% | -157.9M -3.82% | |
Total Stockholders Equity | 327.2M -39.25% | 538.5M -1.17% | 544.9M +3.36% | 527.2M +4.41% | |
Total Shares Outstanding | 59.1M +1.36% | 58.3M +1.35% | 57.5M +1.32% | 56.8M +1.58% | |
Cash Flow | |||||
Cash from Operating Activities | -109.4M +594.56% | -15.8M -223.09% | 12.8M -59.98% | 32.0M -50.19% | |
Capital Expenditures | 998,000 +103.67% | 490,000 +27.94% | 383,000 -43.59% | 679,000 +23.01% | |
Cash from Investing Activities | 94.9M +644.23% | -17.4M +44.58% | -12.1M -124.15% | 49.9M +165.09% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -2.9M +1,774.84% | -155,000 N/A | 0 -100.00% | 734,000 -79.32% | |
Financials Ratio | |||||
Gross Margin | 93.96% -0.36% | 94.31% +2.15% | 92.32% +2.06% | 90.45% -0.007% | |
Operating Margin | -69.95% +241.97% | -20.46% +182.44% | -7.24% -391.10% | 2.49% -84.15% | |
Return on Assets | -38.51% +1,229.02% | -2.90% -840.62% | 0.39% -61.72% | 1.02% -82.62% | |
Return on Equity | -50.93% +1,359.91% | -3.49% -845.47% | 0.47% -61.51% | 1.22% -82.43% | |
Revenue Growth | 8.72% +173.95% | 3.18% +113.11% | -24.27% +356.03% | -5.32% -164.39% | |
Current Ratio | 2.39 -45.50% | 4.39 -11.08% | 4.94 -13.07% | 5.68 -11.64% | |
Cash Ratio | 0.58 -42.89% | 1.02 -33.92% | 1.55 +4.88% | 1.48 +111.06% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow